03/28/2025
6:35 AM | LAVA Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
1:03 PM | BML Investment Partners, L.P. (Filed by)
LAVA Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/28/2025
3:05 PM | LAVA Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
6:12 AM | LAVA Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
7:15 PM | HURLY STEPHEN A (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Morris Charles Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Powell Fred M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | Dhingra Kapil (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | Backstrom Jay T. (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | Kiener Peter A (Reporting)
LAVA Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LVTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | LAVA Therapeutics (Issuer)
WILSON KAREN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
6:29 PM | LAVA Therapeutics (Issuer)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:26 AM | Dhingra Kapil (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:28 AM | Backstrom Jay T. (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:29 AM | Kiener Peter A (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:31 AM | LAVA Therapeutics (Issuer)
Noble James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:32 AM | LAVA Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:34 AM | LAVA Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:35 AM | LAVA Therapeutics (Issuer)
WILSON KAREN J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:19 AM | HURLY STEPHEN A (Reporting)
LAVA Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:20 AM | LAVA Therapeutics (Issuer)
Powell Fred M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
8:21 AM | LAVA Therapeutics (Issuer)
Morris Charles Q (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
7:45 AM | LAVA Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy LVTX Stock Free LVTX Stock Alerts